Spruce Biosciences SPRB
NASDAQ SPRB
$52.24 +0.26 (+0.49%)
As of: Aug 21, 2026 · 9:58 AM EDT

Spruce Biosciences (SPRB) Return on Sales (2023 - 2025)

Spruce Biosciences (SPRB) posted quarterly Return on Sales of 0.69% for Q3 2025, down 54.0% year-over-year from 1.5% in Q3 2024, and down 84.32% quarter-over-quarter from 0.37% in Q2 2025.

Spruce Biosciences (SPRB) Return on Sales (2023 - 2025) Analysis & Trends

Spruce Biosciences (SPRB) has reported Return on Sales for 3 consecutive years, with 0.69% the latest figure, recorded in Q3 2025.

  • In Q3 2025, Return on Sales fell 54.0% year-over-year to 0.69%; the TTM figure through Sep 2025 stood at 0.69% (down 63.0% YoY), while the FY2024 annual figure was 0.11%, down 5.0% from the prior year.
  • Return on Sales declined to 0.69% in Q3 2025 per SPRB's latest filing, from 0.37% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.04% in Q4 2023 and bottomed at 0.69% in Q3 2025.
  • Historically, Return on Sales has averaged 0.19% across 3 years, with a median of 0.07% in 2023.
  • Annual changes were most pronounced in 2024 — Return on Sales rose 1 bps — and 2025, when it plunged 54 bps.
  • Spruce Biosciences' Return on Sales stood at 0.04% in 2023, then slumped by 767 bps to 0.34% in 2024, then tumbled by 104 bps to 0.69% in 2025.
  • Business Quant data shows SPRB's Return on Sales at 0.69% in Q3 2025, 0.37% in Q2 2025, and 0.19% in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Vertex Pharmaceuticals 140.52 Bn 132.67 Bn 2.84 Bn 0.00%
2 Regeneron Pharmaceuticals 86.54 Bn 78.55 Bn 3.93 Bn 0.00%
3 Argenx Se 65.31 Bn 60.13 Bn 1.37 Bn 0.00%
4 Moderna 61.77 Bn 56.64 Bn 52.00 Mn -0.05%
5 BeOne Medicines 42.26 Bn 37.16 Bn 1.53 Bn 0.00%
6 Alnylam Pharmaceuticals 31.19 Bn 27.88 Bn 992.69 Mn 0.00%
7 BioNTech SE 28.71 Bn 10.31 Bn 668.28 Mn 0.00%
8 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 0.00%
9 Royalty Pharma 27.35 Bn 26.52 Bn - 0.00%
10 Spruce Biosciences 127.00 Mn 127.00 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2025 -0.69%
Jun 30, 2025 -0.37%
Mar 31, 2025 -0.19%
Dec 31, 2024 -0.34%
Sep 30, 2024 -0.14%
Jun 30, 2024 -0.06%
Mar 31, 2024 -0.06%
Dec 31, 2023 -0.04%
Sep 30, 2023 -0.04%
Jun 30, 2023 -0.06%
Mar 31, 2023 -0.07%